Download PDF
Exp Clin Endocrinol Diabetes 2021; 129(05): 396-402
DOI: 10.1055/a-0895-5166
Article

Insulin Resistance in Adults with Type 1 Diabetes is Associated with Lower Vitamin D Serum Concentration

Mikołaj Kamiński   *
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Aleksandra Uruska   *
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Anita Rogowicz-Frontczak
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Dawid Lipski
2   Department of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
,
Paweł Niedźwiecki
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Olga Różańska
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Paulina Skonieczna
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Anna Michalska
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Justyna Flotyńska
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Aleksandra Araszkiewicz
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
,
Paweł Uruski
2   Department of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
,
Regina Pawlak
2   Department of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
,
Dorota Zozulińska-Ziółkiewicz
1   Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznań, Poland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Aim Type 1 diabetes mellitus (T1DM) is a disease characterized by an absolute deficiency of endogenous insulin secretion. Insulin resistance (IR) may develop among patients with T1DM. Vitamin D deficiency was reported to be a risk factor in the development of IR. The aim of the study was to assess the relationship between serum concentrations of 25-hydroxyvitamin D (25(OH)D) and IR among patients with T1DM.

Methods The test group consisted of 110 adult patients [males=65 (59%)] with T1DM. Participants were recruited in Poland between 1st October and 30th April in 2015/2016 and 2016/2017. VD serum level was assessed by ELISA array. IR was assessed by estimated Glucose Disposal Rate (eGDR).

Results In the study group 21 (19%) patients were recognized as IR according to eGDR cut-offs (<7.5 mg/kg/min), 52 (47.3%) patients had VD deficiency (25(OH)D<20 ng/ml), 16 (14.5%) patients had 25(OH)D<10 ng/ml. Only 6 (5%) participants reported VD supplementation. Patients with IR, according to eGDR cut-off revealed significantly lower 25(OH)D serum level 15.7 (9.2–28.4) vs. 22.1 (13.0–38.4) ng/ml; p=0.04 as compared to patients without IR. R Spearman analysis found a positive relationship between VD and eGDR (Rs=0.27; p<0.01). Logistic regression analysis revealed significant relationship between the presence of IR and VD serum level/presence of 25(OH)D serum level below 10 ng/ml, both models adjusted to sex, age, BMI, LDL and triglycerides, accordingly (OR=0.95, CI: 0.90–0.99; p=0.04) and (OR=4.19, CI: 1.04–16.93; p=0.04).

Conclusion The serum concentration of Vitamin D is negatively associated with insulin resistance in patients with T1DM and may have clinical implications.

Key words

estimated glucose disposal rate - deficiency - adults - 25(OH)D

* those authors equally contributed to this work.




Publication History

Received: 10 December 2018
Received: 06 April 2019

Accepted: 15 April 2019

Article published online:
02 May 2019

© 2019. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: A common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982; 23: 313-319
    CrossrefPubMedGoogle Scholar
  • 2 Cleland SJ, Fisher BM, Colhoun HM. et al. Insulin resistance in type 1 diabetes: what is „double diabetes“ and what are the risks?. Diabetologia 2013; 56: 1462-1470
    CrossrefPubMedGoogle Scholar
  • 3 Donga E, Dekkers OM, Corssmit EPM. et al. Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: Systematic review and meta-analysis. Eur J Endocrinol 2015; 173: 101-109
    CrossrefPubMedGoogle Scholar
  • 4 Purnell JQ, Zinman B, Brunzell JD. DCCT/EDIC Research Group The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 2013; 127: 180-187
    CrossrefPubMedGoogle Scholar
  • 5 Purnell JQ, Dev RK, Steffes MW. et al. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes 2003; 52: 2623-2629
    CrossrefPubMedGoogle Scholar
  • 6 Orchard TJ, Olson JC, Erbey JR. et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2003; 26: 1374-1379
    CrossrefPubMedGoogle Scholar
  • 7 Dabelea D, Kinney G, Snell-Bergeon JK. et al. Coronary Artery Calcification in Type 1 Diabetes Study. Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1. Diabetes (CACTI) Study. Diabetes 2003; 52: 2833-2839
    PubMedGoogle Scholar
  • 8 Chaturvedi N, Sjoelie AK, Porta M. et al. EURODIAB Prospective Complications Study. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001; 24: 284-289
    CrossrefPubMedGoogle Scholar
  • 9 Orchard TJ, Chang Y-F, Ferrell RE. et al. Nephropathy in type 1 diabetes: A manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 62: 963-970
    CrossrefPubMedGoogle Scholar
  • 10 Thorn LM, Forsblom C, Fagerudd J. et al. FinnDiane Study Group Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 28: 2019-2024
    CrossrefPubMedGoogle Scholar
  • 11 Pop A, Clenciu D, Anghel M. et al. RomDiane Study Group Insulin resistance is associated with all chronic complications in type 1 diabetes. J Diabetes 2016; 8: 220-228
    CrossrefPubMedGoogle Scholar
  • 12 Olson JC, Erbey JR, Williams KV. et al. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes. Ann Epidemiol 2002; 12: 331-337
    CrossrefPubMedGoogle Scholar
  • 13 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223
    CrossrefPubMedGoogle Scholar
  • 14 Matthews DR, Hosker JP, Rudenski AS. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
    CrossrefPubMedGoogle Scholar
  • 15 Williams KV, Erbey JR, Becker D. et al. Can clinical factors estimate insulin resistance in type 1 diabetes?. Diabetes 2000; 49: 626-632
    CrossrefPubMedGoogle Scholar
  • 16 Carlberg C. Molecular endocrinology of vitamin D on the epigenome level. Mol Cell Endocrinol 2017; 453: 14-21
    CrossrefPubMedGoogle Scholar
  • 17 Wu W, Beilhartz G, Roy Y. et al. Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkappaB in differentiating NB4 leukemia cells. Exp Cell Res 2010; 316: 1101-1108
    CrossrefPubMedGoogle Scholar
  • 18 Khanal R, Nemere I. Membrane receptors for vitamin D metabolites. Crit Rev Eukaryot Gene Expr 2007; 17: 31-47
    CrossrefPubMedGoogle Scholar
  • 19 Chun RF, Liu PT, Modlin RL. et al. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis. Front Physiol 2014; 5: 151
    PubMedGoogle Scholar
  • 20 Grübler MR, Gaksch M, Kienreich K. et al. Effects of vitamin D supplementation on plasma aldosterone and renin-a randomized placebo-controlled trial. J Clin Hypertens Greenwich Conn 2016; 18: 608-613
    CrossrefPubMedGoogle Scholar
  • 21 Hyppönen E, Läärä E, Reunanen A. et al. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet Lond Engl 2001; 358: 1500-1503
    CrossrefPubMedGoogle Scholar
  • 22 Cooper JD, Smyth DJ, Walker NM. et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60: 1624-1631
    CrossrefPubMedGoogle Scholar
  • 23 Feng R, Li Y, Li G. et al. Lower serum 25 (OH) D concentrations in type 1 diabetes: A meta-analysis. Diabetes Res Clin Pract 2015; 108: e71-e75
    CrossrefPubMedGoogle Scholar
  • 24 Chiu KC, Chu A, Go VLW. et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825
    CrossrefPubMedGoogle Scholar
  • 25 Hahn S, Haselhorst U, Tan S. et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 577-583
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Forouhi NG, Ye Z, Rickard AP. et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 2012; 55: 2173-2182
    CrossrefPubMedGoogle Scholar
  • 27 Sung C-C, Liao M-T, Lu K-C. et al. Role of vitamin D in insulin resistance. J Biomed Biotechnol 2012; 2012: 634195
    PubMedGoogle Scholar
  • 28 Cordova CMM, de Schneider CR, Juttel ID. et al. Comparison of LDL-cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10 664 patients. Arq Bras Cardiol 2004; 83: 482-487 476–481
    PubMedGoogle Scholar
  • 29 KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49: S12-S154
    CrossrefPubMedGoogle Scholar
  • 30 Płudowski P, Karczmarewicz E, Bayer M. et al. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013; 64: 319-327
    CrossrefPubMedGoogle Scholar
  • 31 Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086SS
    CrossrefPubMedGoogle Scholar
  • 32 Płudowski P, Ducki C, Konstantynowicz J. et al. Vitamin D status in Poland. Pol Arch Med Wewn 2016; 126: 530-539
    PubMedGoogle Scholar
  • 33 Wierzbicka E, Szalecki M, Pludowski P. et al. Vitamin D status, body composition and glycemic control in Polish adolescents with type 1 diabetes. Minerva Endocrinol 2016; 41: 445-455
    PubMedGoogle Scholar
  • 34 Engelen L, Schalkwijk CG, Eussen SJPM. et al. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: The EURODIAB prospective complications study. Cardiovasc Diabetol 2015; 14: 67
    CrossrefPubMedGoogle Scholar
  • 35 Penckofer S, Kouba J, Wallis DE. et al. Vitamin D and Diabetes. Diabetes Educ 2008; 34: 939-954
    CrossrefPubMedGoogle Scholar
  • 36 2017 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin Diabet 20176
    PubMed
  • 37 Rusińska Agnieszka, Płudowski Paweł, Walczak Mieczysław. et al. Vitamin D Supplementation Guidelines for General Population and Groups at Risk of Vitamin D Deficiency in Poland—Recommendations of the Polish Society of Pediatric Endocrinology and Diabetes and the Expert Panel With Participation of National Specialist Consultants and Representatives of Scientific Societies—2018 Update. Front Endocrinol 2018; 9: 246
    CrossrefPubMedGoogle Scholar
  • 38 Cardoso-Sánchez LI, Gómez-Díaz RA, Wacher NH. Vitamin D intake associates with insulin resistance in type 2 diabetes, but not in latent autoimmune diabetes in adults. Nutr Res 2015; 35: 689-699
    CrossrefPubMedGoogle Scholar
  • 39 George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: A systematic review and meta-analysis. Diabet Med J Br Diabet Assoc 2012; 29: e142-e150
    CrossrefPubMedGoogle Scholar
  • 40 Li X, Liao L, Yan X. et al. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2009; 25: 411-416
    CrossrefPubMedGoogle Scholar
  • 41 Uruska A, Araszkiewicz A, Zozulinska-Ziolkiewicz D. et al. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease. Exp Clin Endocrinol Diabetes 2010; 118: 478-484
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Rowe JW, Minaker KL, Pallotta JA. et al. Characterization of the insulin resistance of aging. J Clin Invest 1983; 71: 1581-1587
    CrossrefPubMedGoogle Scholar
  • 43 Kaul K, Apostolopoulou M, Roden M. Insulin resistance in type 1 diabetes mellitus. Metabolism 2015; 64: 1629-1639
    CrossrefPubMedGoogle Scholar
  • 44 Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F
    CrossrefPubMedGoogle Scholar